It’s a sellers’ market for prospective senior living residents: report
By
Kimberly Bonvissuto
Jun 21, 2024
As home resale values continue to be strong and the time period to sell a home remains short, now is a good time for prospective senior living residents to consider selling their homes, according to a...
CDC close to new guidance on COVID-19 restrictions
Feb 24, 2022
The agency wants to give more emphasis to meaningful consequences, such as hospitalizations, emergency room visits and deaths.
AI ‘promising’ for use in geriatrics, but ethical concerns remain, researchers say
By
Aaron Dorman
Sep 22, 2023
A new meta-study on using AI within geriatrics praises AI as a “valuable asset” but still warns about the need for future research and potential ethical concerns.
Allopurinol may cut risk for neurodegenerative diseases
May 19, 2023
Allopurinol linked to 13 to 34 percent lower risk for Parkinson disease, Alzheimer disease, ALS
Social isolation may be independent risk factor for dementia
Jun 10, 2022
Lower gray matter volumes in temporal, frontal, other regions were seen in socially isolated individuals.
Delta variant now fueling 99 percent of U.S. COVID-19 cases
Sep 20, 2021
The delta variant is driving the increase in hospitalizations.
3 keys to reducing turnover in senior living
By
Lois A. Bowers
Jul 11, 2019
Consulting firm Holleran worked with Life Care Services to track engagement and the rate of turnover among 753 employees across 39 senior living campuses over an 18-month period. Here’s what they...
NCAL hits Washington to educate members of Congress
By
Lois A. Bowers
Jun 04, 2017
National Center for Assisted Living members will converge on the nation’s capital Monday and Tuesday with four themes in mind for legislators and their staffs, NCAL Executive Director Scott Tittle...
Silverado first US organization to receive Alzheimer’s Disease International accreditation
By
Kathleen Steele Gaivin
Apr 24, 2024
Irvine, CA-based Silverado has become the first US-based organization to earn accreditation from Alzheimer’s Disease International after becoming the first care provider anywhere to receive the accreditation...
Levetiracetam well-tolerated for Alzheimer’s disease
Oct 01, 2021
It does not improve primary outcome but did improve performance on certain cognitive tasks in those with epileptiform activity.